-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Abbott Laboratories, Lowers Price Target to $118

Benzinga·10/22/2026 13:31:33
Listen to the news
TD Cowen analyst Joshua Jennings maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $135 to $118.